These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 1254381

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of functional adaptation of residual nephrons on the urinary excretion of drugs.
    Schück O, Nádvorníková H, Grafnetterová J, Prát V.
    Yale J Biol Med; 1978; 51(3):351-4. PubMed ID: 735157
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thiamphenicol excretion in subjects with renal insufficiency.
    Azzollini F, Gazzaniga A, Lodola E.
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 3(4):303-8. PubMed ID: 5481994
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Studies on the characteristics of the control system governing sodium excretion in uremic man.
    Slatopolsky E, Elkan IO, Weerts C, Bricker NS.
    J Clin Invest; 1968 Mar; 47(3):521-30. PubMed ID: 5637140
    [Abstract] [Full Text] [Related]

  • 10. [Excretion of group substances ABO (H) with the urine in various kidney diseases].
    Kalinowski M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973 Mar; 100(1):144-63. PubMed ID: 4128512
    [No Abstract] [Full Text] [Related]

  • 11. [Conditions affecting renal excretion of silver by humans. Studies on metabolism of trace elements. VIII].
    Mertz DP, Wilk G, Koschnick R.
    Z Klin Chem Klin Biochem; 1975 Jan; 13(1):13-5. PubMed ID: 1121895
    [Abstract] [Full Text] [Related]

  • 12. [Role of IL-8 and defensins in pathogenesis of chronic glomerulonephritis and pyelonephritis].
    Rebenok AZh, Tikhonov II, Chizh AS.
    Ter Arkh; 1999 Jan; 71(8):62-7. PubMed ID: 10515041
    [Abstract] [Full Text] [Related]

  • 13. Excretion of chloramphenicol and its metabolites by the chronically diseased kidney (with respect to the theory of adaptive nephrons).
    Schück O, Prát V, Grafnetterová J, Kotanová E, Reitschlägerová V, David I.
    Int J Clin Pharmacol; 1974 Jul; 10(1):33-43. PubMed ID: 4851956
    [No Abstract] [Full Text] [Related]

  • 14. Urinary excretion of drugs in chronic renal impairment with respect to changes their tubular handling by residual nephrons.
    Schück O, Grafnetterová J, Nádvorniková H, Prát V.
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):149-54. PubMed ID: 1036732
    [Abstract] [Full Text] [Related]

  • 15. [Semeiological value of the electrophoretic analysis of urinary proteins].
    Traeger J, Manuel Y, Revillard JP, Friès D.
    Bull Mem Soc Med Hop Paris; 1967 Feb 10; 118(3):203-15. PubMed ID: 6058836
    [No Abstract] [Full Text] [Related]

  • 16. [Renal excretion of calcium and magnesium in children with chronic glomerulonephritis and pyelonephritis before and after the development of chronic renal insufficiency].
    Sitnitskaia IG.
    Pediatr Akus Ginekol; 1974 Feb 10; (2):9-10. PubMed ID: 4438031
    [No Abstract] [Full Text] [Related]

  • 17. [The effect of hemodialysis on potassium excretion by residual nephrons].
    Schück O, Teplan V, Nádvorníková H.
    Vnitr Lek; 1991 Jun 10; 37(6):531-4. PubMed ID: 1897136
    [Abstract] [Full Text] [Related]

  • 18. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure.
    Williams PS, Fass G, Bone JM.
    Q J Med; 1988 Apr 10; 67(252):343-54. PubMed ID: 3205906
    [Abstract] [Full Text] [Related]

  • 19. [Serum and urine lysozyme in chronic pyelonephritis and chronic glomerulonephritis].
    Klein U, Klein YM, Stein G, Stelzner A.
    Z Urol Nephrol; 1981 May 10; 74(5):375-84. PubMed ID: 7269823
    [Abstract] [Full Text] [Related]

  • 20. Increased renal excretion of 3 hydroxyproline in patients with active glomerular nephropathies and with polycystic renal disease.
    Chanard J, Szymanowicz A, Brunois JP, Toupance O, Melin JP, Birembaut P, Randoux A, Borel PJ.
    Clin Nephrol; 1982 Feb 10; 17(2):64-9. PubMed ID: 7067168
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.